by rdbiomed | Oct 12, 2020 | LPR, pepsin
Eye examinations could improve the management of patients with laryngopharyngeal reflux disease (LPR), according to a new study. LPR symptoms typically consist of hoarseness, sore throat, the feeling of a lump in the throat and throat clearing. However, it is also... 
by rdbiomed | Sep 14, 2020 | LPR, pepsin
Peptest could prove useful during the current Covid-19 pandemic when access to clinics and more complex clinical diagnostic procedures is restricted or delayed. Many non-essential medical procedures have been postponed or cancelled during the Covid-19 pandemic, with... 
by rdbiomed | Sep 4, 2020 | LPR
Laryngopharyngeal reflux (LPR) – when gastric contents refluxes into the larynx/pharynx – can be diagnosed using a salivary pepsin test, says a study published in the International Archives of Otorhinolaryngology. Pepsin is an enzyme in gastric juice that... 
by rdbiomed | Jan 23, 2020 | LPR
A new UK study with more than 1,000 patients has demonstrated how Peptest can be used to diagnose laryngopharyngeal reflux (LPR) in hospitals, voice clinics and GP surgeries. LPR is a condition responsible for up to 10 per cent of all otolaryngology (ear, nose and... 
by rdbiomed | Nov 11, 2019 | LPR
Peptest has been described as a ‘cost‐effective, non-invasive measurement tool’ to assist office‐based diagnosis of laryngopharangeal reflux disease (LPR) in a new research paper. The study, published in The Laryngoscope – the monthly peer-reviewed medical... 
by rdbiomed | Sep 17, 2019 | LPR
Information on a UK multicentre study evaluating the use of Peptest for patients with laryngopharyngeal reflux (LPR) will be presented at a world-class laryngology conference this month. The Cutting Edge Laryngology Conference showcases the most up-to-date advances in...
Recent Comments